Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer

Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer

Currently, the same first-line chemotherapy is administered to almost all patients suffering from primary ovarian cancer. The high recurrence rate emphasizes the need for precise drug treatment in primary ovarian cancer. Being crucial in ovarian cancer progression and chemotherapeutic resistance, in...

Full description

Bibliographic Details
Main Authors: Katharina Dötzer, Friederike Schlüter, Franz Edler von Koch, Christine E. Brambs, Sabine Anthuber, Sergio Frangini, Bastian Czogalla, Alexander Burges, Jens Werner, Sven Mahner, Barbara Mayer
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Biomedicines
Subjects:
primary ovarian cancer
integrin α2β1
prognostic factor
predictive factor
immune infiltrate
targeted therapy
Online Access:https://www.mdpi.com/2227-9059/9/3/289

Similar Items

Similar Items